Increase in WAT eosinophils and M2 macrophages with increased expression of M2 markers (YM1 and Arg-1). Increase in body insulin sensitivity and glucose tolerance, diminished hepatic steatosis. This evidence concerns the gene ARG1 and fatty liver disease.